Austin Paul Skelton, FNP Registered Nurse - Administrator Medicare: Medicare Enrolled Practice Location: 87983 Territorial Rd, Veneta, OR 97487 Phone: 541-935-2200 Fax: 541-935-6241 |
Sarah Mataisz, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 87860 Territorial Rd Spc 124, Veneta, OR 97487 Phone: 541-517-3924 |
Mrs. Shannon Christine Carpani, BSN, RN, NC-BC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 24887 Strike St, Veneta, OR 97487 Phone: 541-337-5278 |
News Archive
The Elizabeth Glaser Pediatric AIDS Foundation applauds today's announcement from the Joint United Nations Programme on HIV/AIDS that the goal of providing 15 million people with lifesaving antiretroviral therapy (ART) by 2015 has been met nine months ahead of schedule.
Designed to meet the needs of today's hospitals by combining portability with high-end radiology features, Toshiba America Medical Systems, Inc.'s new ViamoTM laptop ultrasound system has received FDA clearance.
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced the enrollment of the first two patients in TRYTON-LM, a prospective, single-arm study evaluating the feasibility of the Tryton stent in conjunction with Abbott's XIENCE PRIME Everolimus Eluting Coronary Stent System to treat stable patients with complex de novo bifurcation lesions involving the left main coronary artery.
Savient Pharmaceuticals, Inc. announced that it has resubmitted its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for KRYSTEXXAâ„¢ (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy. Chronic gout that is refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these drugs are contraindicated.
› Verified 2 days ago